Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Non-Current Liabilities ₹97 Cr₹84 Cr₹126 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of CORONA REMEDIES ?

The latest Total Non-Current Liabilities ratio of CORONA REMEDIES is ₹97 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹97 Cr
Mar2025₹84 Cr
Mar2024₹126 Cr
Mar2023₹45 Cr

How is Total Non-Current Liabilities of CORONA REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹97 Cr
15.70
Mar2025 ₹84 Cr
-33.38
Mar2024 ₹126 Cr
180.69
Mar2023 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,164.1 Cr -2.1% -4.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-2.1%

-4.3%

NA
SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses